IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Performance
Performance Report
Gland Pharma IPO listing price is ₹ 1820.45, issue price is [●], and currently trading at ₹ 1588.60 as on May 30, 2025. Gland Pharma IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Gland Pharma IPO is a Book Building listing on BSE,NSE exchange. The company is based in Hyderabad and caters to Pharmaceutical sector. Citigroup Global Markets India , Haitong Securities India , Kotak Mahindra Capital Company , Nomura Financial Advisory And Securities (India) are the merchant bankers of Gland Pharma IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on [●].
Gland Pharma IPO offer price is ₹ 1500.00 and got listed at ₹ 1820.45. Read Gland Pharma IPO details mentioned above.The IPO of Gland Pharma Limited was listed on 20th November 2020. As of today, Gland Pharma IPO is trading at ₹ 1588.60, compared to the previous day’s close of ₹ 1578.20. Read the report above for detailed IPO performance.
The issue price of Gland Pharma IPO was [●] per equity share.
Gland Pharma IPO was listed at ₹1820.45 on the stock exchange on 20th November 2020. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of May 30, 2025, the current market price of Gland Pharma IPO is ₹ 1588.60.
The 52-week high for Gland Pharma IPO is ₹ 2220.95, while the 52-week low is ₹ 1277.80. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Gland Pharma IPO listed at ₹ 1820.45 against the issue price of [●] per equity share, showing a listing day gain/loss of 320.45 (21.36%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Gland Pharma IPO stock moved from its listing price of ₹ 1820.45 to the current price of ₹1588.60 per equity share, reflecting a change of -12.74% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Gland Pharma IPO issue date of May 30, 2025 and CMP of ₹1588.60, the estimated CAGR is approximately 1.28%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 1
Issue
Price :
[●]
Listing Price :
₹ 1820.45
Previous Day Closing
₹ 1578.20
Gland Pharma IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Gland Pharma Financial Review Page
Merchant Banker(s) of Gland Pharma IPO: Citigroup Global Markets India Private Limited , Haitong Securities India Private Limited , Kotak Mahindra Capital Company Limited , Nomura Financial Advisory And Securities (India) Private Limited
Gland Pharma IPO subscription was 2.06 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Gland Pharma IPO listed at a listing price of 1820.45 against the offer price of 1500.00.
The current market price of Gland Pharma is 1588.60.
Why Us?
